Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.
Saved in:
| Title: | Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial. |
|---|---|
| Authors: | Wedemeyer H; Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie, Hannover, Germany. Electronic address: Wedemeyer.heiner@mh-hannover.de., Aleman S; Karolinska University Hospital/Karolinska Institute, Department of Infectious Diseases, Stockholm, Sweden., Brunetto M; University Hospital of Pisa, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, Pisa, Italy; University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy., Blank A; Heidelberg University Medical Faculty, Heidelberg University Hospital, Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg, Germany., Andreone P; University of Modena and Reggio Emilia, Internal Medicine, Baggiovara Hospital, Modena, Italy., Bogomolov P; State Budgetary Institution of Health Care of Moscow Region, Moscow Regional Research Clinical Institute Named After M.F. Vladimirsky, Moscow, Russian Federation., Chulanov V; FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Mamonova N; FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Geyvandova N; Stavropol Regional Hospital, Stavropol, Russian Federation., Morozov V; Hepatolog, LLC, Samara, Russian Federation., Sagalova O; Federal State-Funded Institution of Higher Education, South Ural State Medical University of Ministry of Health of the Russian Federation, Chelyabinsk, Russian Federation., Stepanova T; Clinic of Modern Medicine, Moscow, Russian Federation., Berger A; Institute for Medical Virology, German Centre for Infection Research, External Partner Site Frankfurt, University Hospital, Goethe University, Frankfurt am Main, Germany., Ciesek S; Institute for Medical Virology, German Centre for Infection Research, External Partner Site Frankfurt, University Hospital, Goethe University, Frankfurt am Main, Germany., Manuilov D; Gilead Sciences, Foster City, CA, United States., Mercier RC; Gilead Sciences, Foster City, CA, United States., Da BL; Gilead Sciences, Foster City, CA, United States., Chee GM; Gilead Sciences, Foster City, CA, United States., Li M; Gilead Sciences, Foster City, CA, United States., Flaherty JF; Gilead Sciences, Foster City, CA, United States., Lau AH; Gilead Sciences, Foster City, CA, United States., Osinusi A; Gilead Sciences, Foster City, CA, United States., Schulze Zur Wiesch J; Universitätsklinikum Hamburg-Eppendorf, Medizinische Klinik Studienambulanz Hepatologie, Hamburg, Germany., Cornberg M; Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie, Hannover, Germany., Zeuzem S; University Hospital Frankfurt, Department of Medicine, Frankfurt am Main, Germany., Lampertico P; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; CRC A. M. and A. Migliavacca Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. |
| Source: | Journal of hepatology [J Hepatol] 2024 Oct; Vol. 81 (4), pp. 621-629. Date of Electronic Publication: 2024 May 09. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38734383 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wedemeyer+H%22">Wedemeyer H</searchLink>; Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie, Hannover, Germany. Electronic address: Wedemeyer.heiner@mh-hannover.de.<br /><searchLink fieldCode="AU" term="%22Aleman+S%22">Aleman S</searchLink>; Karolinska University Hospital/Karolinska Institute, Department of Infectious Diseases, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Brunetto+M%22">Brunetto M</searchLink>; University Hospital of Pisa, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, Pisa, Italy; University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Blank+A%22">Blank A</searchLink>; Heidelberg University Medical Faculty, Heidelberg University Hospital, Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Andreone+P%22">Andreone P</searchLink>; University of Modena and Reggio Emilia, Internal Medicine, Baggiovara Hospital, Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Bogomolov+P%22">Bogomolov P</searchLink>; State Budgetary Institution of Health Care of Moscow Region, Moscow Regional Research Clinical Institute Named After M.F. Vladimirsky, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Chulanov+V%22">Chulanov V</searchLink>; FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Mamonova+N%22">Mamonova N</searchLink>; FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Geyvandova+N%22">Geyvandova N</searchLink>; Stavropol Regional Hospital, Stavropol, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Morozov+V%22">Morozov V</searchLink>; Hepatolog, LLC, Samara, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Sagalova+O%22">Sagalova O</searchLink>; Federal State-Funded Institution of Higher Education, South Ural State Medical University of Ministry of Health of the Russian Federation, Chelyabinsk, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Stepanova+T%22">Stepanova T</searchLink>; Clinic of Modern Medicine, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Berger+A%22">Berger A</searchLink>; Institute for Medical Virology, German Centre for Infection Research, External Partner Site Frankfurt, University Hospital, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Ciesek+S%22">Ciesek S</searchLink>; Institute for Medical Virology, German Centre for Infection Research, External Partner Site Frankfurt, University Hospital, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Manuilov+D%22">Manuilov D</searchLink>; Gilead Sciences, Foster City, CA, United States.<br /><searchLink fieldCode="AU" term="%22Mercier+RC%22">Mercier RC</searchLink>; Gilead Sciences, Foster City, CA, United States.<br /><searchLink fieldCode="AU" term="%22Da+BL%22">Da BL</searchLink>; Gilead Sciences, Foster City, CA, United States.<br /><searchLink fieldCode="AU" term="%22Chee+GM%22">Chee GM</searchLink>; Gilead Sciences, Foster City, CA, United States.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Gilead Sciences, Foster City, CA, United States.<br /><searchLink fieldCode="AU" term="%22Flaherty+JF%22">Flaherty JF</searchLink>; Gilead Sciences, Foster City, CA, United States.<br /><searchLink fieldCode="AU" term="%22Lau+AH%22">Lau AH</searchLink>; Gilead Sciences, Foster City, CA, United States.<br /><searchLink fieldCode="AU" term="%22Osinusi+A%22">Osinusi A</searchLink>; Gilead Sciences, Foster City, CA, United States.<br /><searchLink fieldCode="AU" term="%22Schulze+Zur+Wiesch+J%22">Schulze Zur Wiesch J</searchLink>; Universitätsklinikum Hamburg-Eppendorf, Medizinische Klinik Studienambulanz Hepatologie, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Cornberg+M%22">Cornberg M</searchLink>; Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Zeuzem+S%22">Zeuzem S</searchLink>; University Hospital Frankfurt, Department of Medicine, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Lampertico+P%22">Lampertico P</searchLink>; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; CRC A. M. and A. Migliavacca Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228503886%22">Journal of hepatology</searchLink> [J Hepatol] 2024 Oct; Vol. 81 (4), pp. 621-629. <i>Date of Electronic Publication: </i>2024 May 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8503886 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0641 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201688278%22">01688278 </searchLink><i>NLM ISO Abbreviation: </i>J Hepatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38734383 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jhep.2024.05.001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 621 Titles: – TitleFull: Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wedemeyer H – PersonEntity: Name: NameFull: Aleman S – PersonEntity: Name: NameFull: Brunetto M – PersonEntity: Name: NameFull: Blank A – PersonEntity: Name: NameFull: Andreone P – PersonEntity: Name: NameFull: Bogomolov P – PersonEntity: Name: NameFull: Chulanov V – PersonEntity: Name: NameFull: Mamonova N – PersonEntity: Name: NameFull: Geyvandova N – PersonEntity: Name: NameFull: Morozov V – PersonEntity: Name: NameFull: Sagalova O – PersonEntity: Name: NameFull: Stepanova T – PersonEntity: Name: NameFull: Berger A – PersonEntity: Name: NameFull: Ciesek S – PersonEntity: Name: NameFull: Manuilov D – PersonEntity: Name: NameFull: Mercier RC – PersonEntity: Name: NameFull: Da BL – PersonEntity: Name: NameFull: Chee GM – PersonEntity: Name: NameFull: Li M – PersonEntity: Name: NameFull: Flaherty JF – PersonEntity: Name: NameFull: Lau AH – PersonEntity: Name: NameFull: Osinusi A – PersonEntity: Name: NameFull: Schulze Zur Wiesch J – PersonEntity: Name: NameFull: Cornberg M – PersonEntity: Name: NameFull: Zeuzem S – PersonEntity: Name: NameFull: Lampertico P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1600-0641 Numbering: – Type: volume Value: 81 – Type: issue Value: 4 Titles: – TitleFull: Journal of hepatology Type: main |
| ResultId | 1 |